Dextera Surgical will sell nearly all of its assets to Aesculap.
Here are four insights:
1. The sale will close Feb. 20.
2. Dextera Surgical's portfolio includes the MicroCutter 5/80 Stapler, PAS-Port and C-Port automated anastomosis systems.
3. Dextera Surgical filed a voluntary Chapter 11 petition in December 2017.
4. Aesculap offers minimally invasive instruments for neurosurgery and cardiovascular surgery, among other solutions.